Skip to Main content Skip to Navigation
Journal articles

The role of GSK-3 in synaptic plasticity.

Abstract : Glycogen synthase kinase-3 (GSK-3), an important component of the glycogen metabolism pathway, is highly expressed in the CNS. It has been implicated in major neurological disorders including Alzheimer's disease, schizophrenia and bipolar disorders. Despite its central role in these conditions it was not known until recently whether GSK-3 has neuronal-specific functions under normal conditions. However recent work has shown that GSK-3 is involved in the regulation of, and cross-talk between, two major forms of synaptic plasticity, N-methyl-D-aspartate receptor (NMDAR)-dependent long-term potentiation (LTP) and NMDAR-dependent long-term depression (LTD). The present article summarizes this recent work and discusses its potential relevance to the treatment of neurological disorders.
Document type :
Journal articles
Complete list of metadata

Cited literature [60 references]  Display  Hide  Download
Contributor : Stephane Peineau Connect in order to contact the contributor
Submitted on : Wednesday, January 16, 2013 - 5:08:23 PM
Last modification on : Wednesday, January 16, 2013 - 6:22:02 PM
Long-term archiving on: : Saturday, April 1, 2017 - 6:24:14 AM


Files produced by the author(s)




Stéphane Peineau, Clarrisa Bradley, Changiz Taghibiglou, Andrew Doherty, Zuner A. Bortolotto, et al.. The role of GSK-3 in synaptic plasticity.. British Journal of Pharmacology, Wiley, 2008, 153 Suppl 1, pp.S428-37. ⟨10.1038/bjp.2008.2⟩. ⟨inserm-00777058⟩



Record views


Files downloads